The natural history of parallel transjugular intrahepatic portosystemic stent shunts using uncovered stent: the role of host-related factors

Liver Int. 2006 Jun;26(5):572-8. doi: 10.1111/j.1478-3231.2006.01264.x.

Abstract

Objectives: Parallel shunts (PS) are used in the management of transjugular intrahepatic portosystemic stent-shunt (TIPS) insufficiency, a major limitation of the technique. This study describes the natural history of PS, and uses them as a model to assess the role of host factors in the development of primary shunt insufficiency.

Methods: Out of 338 patients with TIPS, 40 (11.8%) patients required insertion of a PS. Baseline and follow-up data of these patients were collected. Regular shunt surveillance involved biannual clinic visits and transjugular portography.

Results: The non-PS group (group 1; n = 298) and the PS group (group 2; n = 40) had similar baseline demographic and disease characteristics. Index shunts of both groups and the PS produced a significant portal pressure gradient drop (P < 0.001), which was less in the index shunts of Group 2 (P < 0.02 for both). PS had similar cumulative shunt patency rates to those of the index shunts of Group 1, and both were greater than those of index shunts in Group 2 (P < 0.001 for both). The intervention rate (number of interventions/number of check portograms x 100) was similar for PS and the index shunts of Group 1 (38.7% and 43% respectively), but was significantly higher in the index shunts of Group 2 (85.6%; P < 0.01 for both). In Group 1 and Group 2, 144 patients (48.3%) and 21 patients (52.5%) died during follow-up after a median period of 23.4 and 8.9 months respectively.

Conclusions: These findings do not support the hypothesis that shunt insufficiency is related to host factors.

MeSH terms

  • Adult
  • Aged
  • Biological Factors
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Portal Pressure
  • Portasystemic Shunt, Transjugular Intrahepatic / methods*
  • Portasystemic Shunt, Transjugular Intrahepatic / standards
  • Retrospective Studies
  • Stents / standards*
  • Survival Rate

Substances

  • Biological Factors